| |
| |
|
| Insider
Information: |
Powala Christopher |
| Relationship: |
Chief Reg & Develop Of... |
| City: |
Malvern |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
141,729 |
|
|
Indirect Shares
|
130,434 |
|
|
| Direct
Value |
$165,823 |
|
|
|
Indirect Value
|
$152,608 |
|
|
| Total
Shares |
272,163 |
|
|
| Total
Value |
$318,431 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aclaris Therapeutics, Inc. |
ACRS |
Chief Reg & Develop Of... |
2019-02-01 |
141,729 |
2019-02-01 |
130,434 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Reg & Develop Officer |
• – – |
2019-02-01 |
4 |
D |
$6.96 |
$7,753 |
D/D |
(1,114) |
141,729 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Reg & Develop Officer |
• – – |
2019-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,400 |
142,843 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Reg & Develop Officer |
• – – |
2018-12-18 |
4 |
D |
$6.30 |
$2,810 |
D/D |
(446) |
139,443 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Reg & Develop Officer |
• – – |
2018-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,625 |
139,889 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Reg & Develop Officer |
• – – |
2018-12-15 |
4 |
D |
$7.31 |
$2,610 |
D/D |
(357) |
138,264 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Reg & Develop Officer |
• – – |
2018-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,300 |
138,621 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Reg & Develop Officer |
• – – |
2018-05-07 |
4 |
D |
$18.10 |
$26,788 |
D/D |
(1,480) |
137,321 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Reg & Develop Officer |
• – – |
2018-05-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,200 |
138,801 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2017-12-18 |
4 |
D |
$24.12 |
$11,915 |
D/D |
(494) |
133,601 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2017-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,625 |
134,095 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2017-12-15 |
4 |
D |
$24.23 |
$9,571 |
D/D |
(395) |
132,470 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2017-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,300 |
132,865 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2016-12-18 |
4 |
D |
$31.25 |
$15,438 |
D/D |
(494) |
131,565 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2016-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,625 |
132,059 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Operating OfficerOfficer |
• – – |
2015-10-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
130,434 |
|
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Operating OfficerOfficer |
• – – |
2015-10-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
130,434 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
